Director Tredwell bought 59 TRS shares at $39.38; 4 of 5 prior TRS buys showed positive 90d returns; stock down -8.2% from 52-week high.
Director Daniel P Tredwell purchased 59 shares of TriMas at $39.38 on 2026-03-05, a modest addition to his 60.5K share position. His transaction history at this ticker shows a pattern of positive timing: 4 of 5 prior buys at TRS resulted in positive 90-day returns, ranging from +13.0% to +43.8%, indicating his prior purchases have consistently preceded periods of stock appreciation. At the current price of $36.75, the stock sits 8.2% below its 52-week high and has gained 8.8% over the past 90 days, a relatively stable backdrop. The company's fundamentals reflect operational headwinds—annual revenue contracted 30.2% year-over-year despite a healthy P/E of 9.88—suggesting this transaction may warrant closer examination of whether prior timing success will persist in a challenged revenue environment.
Director Tredwell buys 73 TRS shares at $31.94; stock down 21.9% from 52-week high, extends 5-buy pattern at ticker with mixed timing.
Tredwell Daniel P, a director at TRIMAS CORP, purchased 73 shares at $31.94 on 2025-11-12, bringing his post-transaction holdings to 60,483 shares. The purchase occurs as the stock trades at $31.24 current price, representing a -21.9% decline from its 52-week high of $40.02, and the stock has declined -14.8% over the prior 30 days and -15.0% over 90 days. This buy extends a pattern of 5 prior purchases at TRS: his prior trades at this ticker show mixed 90-day outcomes (3 of 5 well-timed, with results ranging from -13.6% to +43.8%), and his cross-ticker track record across 11 prior buys averages +6.6% at 90 days with a 63.64% win rate. The small transaction size (+73 shares, +0.1% vs pre-transaction holdings) and the stock's recent price weakness are the key observations in evaluating this purchase alongside the company's fundamentals: P/E of 28.93, $269.3M latest quarterly revenue, and +3.5% annual growth.
Director Tredwell Daniel P buys 66 TRS shares at $35.39; stock up 23.7% in 30 days, 51.5% in 90 days.
Tredwell purchased 66 shares at $35.39 on 2025-08-11, adding modestly to a large existing position of 60.3K shares. The stock has appreciated significantly since purchase: +23.7% over 30 days and +51.5% over 90 days, now trading at $37.47, a new 52-week high. His same-ticker history at TRS shows 4 of 5 prior buys were well-timed at the 90-day mark, including three consecutive buys in early 2025 that delivered +11.8%, +12.9%, and +43.8% gains respectively. The latest purchase extends a pattern of consistent, successfully-timed accumulation in this stock, though the modest 66-share transaction size relative to his 60.4K-share position suggests incremental rather than conviction-driven activity.
Director Tredwell bought 94 TRS shares at $24.72; modest accumulation against mixed record.
Director Daniel P Tredwell purchased 94 shares at $24.72 on 2025-05-12, increasing his holdings to 60,343 shares—a 0.2% increase. The transaction size ($2,344.36) is small relative to his existing position, and the purchase occurred while the stock was -14.8% from its 52-week high of $28.32, though up 14.9% over the past 30 days. Tredwell's prior trades at TRS show inconsistent timing: of 5 recent purchases, only 1 of 3 with measurable 90-day outcomes achieved positive returns, with his same-ticker 90-day win rate at 33.3% (1 of 3). His cross-ticker track record shows a 57.14% 90-day win rate across 9 prior buys with an average 90-day return of -0.1%, providing limited predictive signal. The current P/E of 30.92 and fundamentals (revenue $241.7M, net income $12.4M, annual growth +3.5%) appear stable, but the modest position increase and checkered execution history at this ticker offer modest evidence of conviction.
Director Tredwell buys 95 shares of TRS at $22.78 amid cluster of 5 other insider purchases within 14 days
Director Tredwell Daniel P purchased 95 shares of TRIMAS CORP at $22.78, adding to a modest holding of 56,108 shares. This transaction occurs within a cluster of 5 other insider buys within the past 14 days, suggesting coordinated or converging interest at this price level. At the broader level, Tredwell's cross-ticker track record shows 8 prior buys with an average 90-day return of -0.1% and a 57.14% win rate, while his same-ticker history at TRS reflects mixed results: 2 of 4 prior measurable 90-day outcomes were positive (buys in Aug 2024 and Mar 2024 returned +15.2% and +8.6% respectively), while two were negative (Nov 2024 and May 2024 returned -13.6% and -11.3%). The stock currently trades at $24.15, down 14.7% from its 52-week high, and the company carries a P/E of 92.88 with modest fundamentals (quarterly revenue of $229.4M, net income of $2.5M, and annual growth of +3.5%). The cluster buy pattern warrants attention as a potential signal of insider assessment, though the individual transaction size ($2.2K) is small relative to holdings and the company's valuation metrics remain elevated.
Director Tredwell Daniel P bought 5,000 shares of TRS at $20.67; stock down 26.0% from 52-week high amid cluster pattern.
Director Tredwell Daniel P purchased 5,000 shares at $20.67 on 2025-02-28, raising his holdings to 56.0K shares (+9.8% vs pre-transaction), concurrent with 3 other insiders buying within the past 14 days. His cross-ticker track record shows 7 prior buys with a 57.14% 90-day win rate and average 90d return of -0.1%, while his same-ticker history at TRS over 5 prior trades is mixed: 3 of 5 were well-timed at the 90-day mark, but the most recent buy on 2024-11-11 posted a 90d return of -13.6%. The current stock price of $20.96 is 26.0% below the 52-week high of $28.32 and down 13.7% over the last 30 days, placing the trade at a depressed recent valuation. With a P/E of 80.62 and net income of $2.5M on revenue of $229.4M, fundamental support for valuation is limited, and the cluster activity warrants monitoring as a potential early indicator of insider perspective on near-term risk or opportunity.
Director Tredwell buys 79 shares of TRS at $27.51; stock now $26.49, down 6.5% from 52-week high.
Tredwell Daniel P, a director, purchased 79 shares at $27.51, adding modestly to a 51.0K-share position and representing a +0.2% increase in holdings. The transaction occurred near the top of the stock's recent range ($22.97–$28.32), with the current price of $26.49 now 6.5% below the 52-week high. Across his prior five trades at TRS, Tredwell has demonstrated mixed timing outcomes: 3 of the 5 prior buys achieved positive 90-day returns, but his most recent buy (August 2024) has delivered +4.2% over 30 days and +15.2% over 90 days, while his next-most-recent buy (May 2024) declined -11.3% over 90 days. The company shows limited growth dynamics (revenue +1.1% year-over-year, P/E of 40.75), suggesting the transaction occurs in a mature, valuation-sensitive context rather than a growth inflection.
Director Tredwell Daniel P buys 91 TRS shares at $23.71; stock down 14.6% from 52-week high.
Tredwell Daniel P purchased 91 shares of TRIMAS CORP at $23.71 on 2024-08-12, a modest addition to his 50.9K share position. The transaction occurs against a backdrop of recent weakness: the stock trades 14.6% below its 52-week high and has declined 8.3% over the prior 30 days. Reviewing his prior trades at TRS, the insider has shown mixed timing—3 of 5 prior buys eventually posted positive 90-day returns, but his most recent TRS purchase on 2024-05-10 at a higher price point saw a 90-day decline of -11.3%, suggesting current valuations may not yet offer clear reversal signals. The company's fundamentals show modest growth (revenue up 1.1% year-over-year) and a moderate P/E of 23.75, providing limited evidence of either distress or exceptional opportunity at the current price level.
